Lu Si
9PUBLICATIONS
36CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 25, 2025
CNDP1 Overexpression by Promoter Hypomethylation Predicts Poor Prognosis and Immunotherapy Response in Mucosal Melanoma.Jia Jia, Junjie Gu, Lina Gao
|Feb 06, 2025
Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: phase Ia/Ib trial results and biomarker insights.Xuan Wang, Hui Tian, Zhihong Chi
|Jan 06, 2025
Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3-year survival update and multi-omics analysis.Jie Dai, Tianxiao Xu, Lifeng Li
|Oct 17, 2024
Phase Ib study of anti-PD-L1 monoclonal antibody socazolimab in combination with nab-paclitaxel as first-line therapy for advanced urothelial carcinoma.Bixia Tang, Jun Xiao, Zhihong Chi
|Aug 20, 2024
Predominance of hyperprogression in mucosal melanoma during anti-PD-1 monotherapy treatment.Li Zhou, Min Cao, Haibin Zhu
Pageof 2